SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards
GÖTEBORG, Sweden and ROSTOCK, Germany, May 14, 2019 / B3C newswire / -- SensID GmbH, a leading specialist in the development and manufacturing of high quality reference standards for molecular diagnostics, and TATAA Biocenter AB, a pioneer within the industry and leading provider of high quality molecular analyses announced today the signing of a distribution agreement. SensID gives TATAA full access to its continuously growing product portfolio for Molecular Diagnostics, and TATAA will represent SensID in Sweden, Denmark, Norway, Finland, Czech and Slovak Republics.
“With its strong focus on reference materials for Molecular Diagnostics, SensID is a perfect solution provider for our high performance accredited services. The SenseID products are also most attractive to our quality conscious customers”, says Professor Mikael Kubista, CEO and founder of TATAA Biocenter.
Björn Nowack, CEO and co-founder of SensID states: “This agreement is further confirmation of the high commercial value of our product concept and business model. We are very proud that TATAA, an international leader in the field of Molecular Diagnostics, is now a partner supporting fast market entry of our novel MDx reference materials.”
About SensID – Bringing Precision to MDx
SensID, headquartered in Rostock, Germany, is specialized in the development, manufacturing and marketing of reference materials and quality controls for molecular, DNA based diagnostics. We offer to our customers reference materials and quality controls precisely characterized and manufactured in compliance with the highest standards. Our continuously growing product portfolio offers ideal solution options for your R&D programs as well as assay and instrument validation requirements. They can serve as external controls, support accreditation, ring trials, conformity assessment, and should be a part of your diagnostic kits.
About TATAA Biocenter AB – Best Nucleic Acid Analysis Service Provider Europe
TATAA Biocenter is the world’s largest organizer of hands-on training in quantitative real-time PCR and Next Generation Sequencing, Europe’s leading provider of nucleic acid analysis services, and Sweden’s most comprehensive distributor of products for nucleic acids analysis. TATAA Biocenter offers a seamless workflow for high quality nucleic acids analysis from experimental design, sample preparation, quality control, and analysis, meeting the specific requirements for compliance with ISO17025 standard. Founded in 2001, TATAA Biocenter has laboratories in Gothenburg, Sweden, and in Prague, Czech Republic. In 2013 TATAA Biocenter was presented the Frost & Sullivan Award for Customer Value Leadership as Best-in-Class Services for Analyzing Genetic Material and in 2019 TATAA Biocenter was named “Best Nucleic Acid Analysis Service Provider – Europe” by Global Health & Pharma.
For further information see www.tataa.com or contact us on firstname.lastname@example.org.
18057 Rostock, Germany
+49 160 55 234 72
Published by B3C newswire and shared through Newronic®